NEWS

Grupo Natac S.L. and Radient Technologies Launch Natac Solutions at SupplySide West

Advanced-Efficacy Extracts Offer Condition-Specific Functional Benefits

> Edmonton, Canada and Madrid, Spain (November 7, 2018) – Radient Technologies Inc. (TSX Venture: RTI) and Grupo Natac S.L. (Natac) are pleased to announce the formal launch of their joint venture Natac Solutions at SupplySide West November 7-9, 2018 in Las Vegas, Nevada.  Natac Solutions will bring revolutionary health and wellness ingredients to the market and will be showing at SupplySide West (Booth 5334) for its first industry appearance.
“We saw an opportunity with our plant-based, clinically validated ingredients and RTI’s innovative extraction technology,” says Antonio Delgado, Natac CEO. “By leveraging each other’s strengths, we see unlimited potential in what we can create. We believe our combined approach to botanical extractions allows us—and our customers—to take the next step in the nutraceutical industry.”
El enfoque de Natac para el desarrollo de ingredientes preserva la integridad del perfil holístico de la planta (Perfil completo de la planta) y, al mismo tiempo, extrae todos los ingredientes fitoquímicos beneficiosos para que puedan trabajar juntos de forma natural. El producto final ofrece extractos concentrados con una calidad constante y una biodisponibilidad excepcional en dosis más bajas. La tecnología patentada RTI (MAP ™) mejora el proceso de extracción al aumentar el rendimiento y la pureza al tiempo que reduce el tiempo de procesamiento y la energía.
Natac’s approach to ingredient development preserves the integrity of the holistic plant profile (Full Plant Profile) and simultaneously extracts all beneficial phytochemical ingredients so they can work together as nature intended. The final product offers a concentrated extracts with consistent quality and exceptional bioavailability in lower doses.  RTI’s patented technology (MAP™), enhances the extraction process by increasing yield and purity while reducing processing time and energy.
“By implementing our disruptive, groundbreaking technology with Natac’s products, we believe that Natac Solutions will be able to provide the market place with innovative ingredients backed by strong science,” says Denis Taschuk, RTI CEO. “That’s a win-win for us and for brands looking to incorporate botanical ingredients in their products.”
The joint venture creates value both for the companies involved and the health and wellness brands they serve. For more information on Natac Solutions, visit www.NatacGroup.com and Booth 5334 at SupplySide West on Nov. 8-9, 2018.  
About Radient
Radient extracts natural compounds from a range of biological materials using microwave assisted processing (“MAP™”), a patented technology platform that provides superior product outcomes in terms of ingredient purity, yield, and cost.
Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health and personal care markets.
Visit www.radientinc.com for more information.
 
Contact
Denis Taschuk, Chief Executive Officer, dtaschuk@radientinc.com,
+1 (780) 465-1318;
Christine O’Neil, Senior Vice President Corporate Development, coneil@natacgroup.com
Caitlin Cheadle, Investor Relations, ccheadle@radientinc.com
 
About Natac
Natac researches, develops, manufactures, and markets natural ingredients for use in food supplements, functional foods, and natural pharmaceutical ingredients, primarily plant extracts and functional lipids. The company’s sustainable business model involves building and maintaining relationships with farmers, large food companies, and other stakeholders, and this allows the company to offer ingredients from different regions and extracted with innovative technologies.
The integration of a variety of processes, technologies, and equipment into an unparalleled synergy enables it to control the cycle from the farmer to the finished product.
Visit www.natacgroup.com for more information.
 
Contact
Noela Gonzalez, Executive Director-Business Development, ngonzalez@natacgroup.com
+34 918-276-470
 
Forward Looking Information
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, without limitation, statements regarding the growth of the Company’s business operations; the impact of the JV, the ability to enter into a binding joint venture agreement; the Company’s ability to grow its business in the health and wellness sector and the Company’s future plans. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of Radient, as the case may be, to be materially different from those expressed or implied by such forward-looking information. Although Radient has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking information. Radient does not undertake to update any forward-looking information, except in accordance with applicable securities laws.
 
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.